Bryan Bergman
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin Resistance | 48 | 2023 | 1180 | 8.300 |
Why?
| Muscle, Skeletal | 37 | 2023 | 1515 | 5.380 |
Why?
| Sphingolipids | 7 | 2023 | 62 | 2.930 |
Why?
| Triglycerides | 15 | 2022 | 519 | 2.570 |
Why?
| Adipose Tissue | 16 | 2023 | 606 | 2.480 |
Why?
| Diabetes Mellitus, Type 2 | 20 | 2023 | 2174 | 2.460 |
Why?
| Diglycerides | 7 | 2020 | 56 | 2.380 |
Why?
| Insulin | 25 | 2023 | 2162 | 1.980 |
Why?
| Exercise | 12 | 2020 | 1657 | 1.920 |
Why?
| Obesity | 29 | 2023 | 2746 | 1.830 |
Why?
| Blood Glucose | 27 | 2019 | 1939 | 1.830 |
Why?
| Physical Endurance | 12 | 2020 | 231 | 1.670 |
Why?
| Fasting | 6 | 2019 | 264 | 1.650 |
Why?
| Rest | 6 | 2017 | 104 | 1.310 |
Why?
| Glucose Clamp Technique | 19 | 2021 | 194 | 1.270 |
Why?
| Liver | 12 | 2019 | 1816 | 1.240 |
Why?
| Lipogenesis | 4 | 2017 | 66 | 1.200 |
Why?
| Fatty Acids, Nonesterified | 10 | 2022 | 167 | 1.130 |
Why?
| Intra-Abdominal Fat | 4 | 2022 | 98 | 1.060 |
Why?
| Prediabetic State | 5 | 2016 | 234 | 1.050 |
Why?
| Lipids | 4 | 2020 | 607 | 1.000 |
Why?
| Muscle Fibers, Skeletal | 4 | 2023 | 192 | 0.990 |
Why?
| Glucose | 9 | 2023 | 953 | 0.990 |
Why?
| Glucose Tolerance Test | 11 | 2021 | 368 | 0.940 |
Why?
| Lipid Metabolism | 11 | 2023 | 477 | 0.900 |
Why?
| Dietary Fats | 6 | 2020 | 322 | 0.850 |
Why?
| Diabetes Mellitus, Type 1 | 18 | 2019 | 3360 | 0.820 |
Why?
| Carnitine | 2 | 2021 | 65 | 0.810 |
Why?
| Athletes | 6 | 2020 | 353 | 0.730 |
Why?
| Tandem Mass Spectrometry | 3 | 2021 | 421 | 0.690 |
Why?
| Energy Metabolism | 4 | 2021 | 767 | 0.670 |
Why?
| Humans | 78 | 2023 | 118974 | 0.650 |
Why?
| Adult | 38 | 2021 | 31512 | 0.620 |
Why?
| Glucose Intolerance | 4 | 2014 | 139 | 0.610 |
Why?
| Male | 57 | 2022 | 57801 | 0.610 |
Why?
| Adipocytes | 2 | 2023 | 199 | 0.600 |
Why?
| Lactic Acid | 7 | 2009 | 282 | 0.600 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2019 | 490 | 0.590 |
Why?
| Phosphatidylethanolamines | 2 | 2017 | 66 | 0.590 |
Why?
| Ceramides | 5 | 2023 | 104 | 0.580 |
Why?
| Female | 55 | 2023 | 61565 | 0.570 |
Why?
| Choristoma | 1 | 2015 | 24 | 0.540 |
Why?
| Phosphatidylcholines | 1 | 2016 | 133 | 0.530 |
Why?
| Mitochondria, Muscle | 5 | 2021 | 97 | 0.520 |
Why?
| Hyperglycemia | 3 | 2014 | 312 | 0.470 |
Why?
| Myocardium | 2 | 2009 | 970 | 0.460 |
Why?
| Smoking | 2 | 2012 | 1487 | 0.460 |
Why?
| Benzhydryl Compounds | 1 | 2013 | 60 | 0.450 |
Why?
| Phenols | 1 | 2013 | 85 | 0.440 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2012 | 46 | 0.440 |
Why?
| Atrial Function | 2 | 2009 | 11 | 0.440 |
Why?
| Body Composition | 8 | 2021 | 653 | 0.440 |
Why?
| Culture Media, Conditioned | 2 | 2022 | 112 | 0.430 |
Why?
| Homeostasis | 1 | 2016 | 594 | 0.430 |
Why?
| Oxidation-Reduction | 7 | 2021 | 940 | 0.420 |
Why?
| Lipoprotein Lipase | 2 | 2015 | 68 | 0.410 |
Why?
| Physical Fitness | 4 | 2004 | 179 | 0.410 |
Why?
| Sleep | 3 | 2021 | 660 | 0.390 |
Why?
| Glycerol | 5 | 2015 | 88 | 0.390 |
Why?
| Middle Aged | 24 | 2020 | 27617 | 0.390 |
Why?
| Incretins | 1 | 2010 | 15 | 0.380 |
Why?
| Fatty Acids | 4 | 2023 | 407 | 0.370 |
Why?
| Subcutaneous Fat | 2 | 2022 | 82 | 0.370 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 44 | 0.370 |
Why?
| Sleep Deprivation | 3 | 2021 | 164 | 0.360 |
Why?
| Pyrazines | 1 | 2010 | 72 | 0.360 |
Why?
| Sarcolemma | 2 | 2020 | 29 | 0.350 |
Why?
| Triazoles | 1 | 2010 | 134 | 0.350 |
Why?
| Physical Education and Training | 2 | 1999 | 62 | 0.340 |
Why?
| Insulin-Secreting Cells | 2 | 2010 | 330 | 0.340 |
Why?
| Cytosol | 2 | 2020 | 221 | 0.340 |
Why?
| Cardiac Pacing, Artificial | 1 | 2009 | 85 | 0.330 |
Why?
| Thinness | 2 | 2007 | 91 | 0.310 |
Why?
| Cross-Sectional Studies | 6 | 2023 | 4552 | 0.310 |
Why?
| Animals | 25 | 2023 | 33381 | 0.310 |
Why?
| Endoplasmic Reticulum | 2 | 2020 | 241 | 0.300 |
Why?
| T-Lymphocytes | 5 | 2000 | 1774 | 0.290 |
Why?
| Pulmonary Gas Exchange | 3 | 2007 | 117 | 0.290 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2018 | 157 | 0.270 |
Why?
| Body Mass Index | 5 | 2018 | 2092 | 0.270 |
Why?
| Polycystic Ovary Syndrome | 2 | 2019 | 157 | 0.270 |
Why?
| Palmitates | 2 | 2018 | 19 | 0.260 |
Why?
| Islets of Langerhans | 5 | 2000 | 739 | 0.260 |
Why?
| Heart Rate | 1 | 2008 | 729 | 0.250 |
Why?
| Young Adult | 11 | 2019 | 10793 | 0.250 |
Why?
| Energy Intake | 3 | 2021 | 447 | 0.250 |
Why?
| Adiposity | 4 | 2022 | 516 | 0.250 |
Why?
| Prostatic Neoplasms | 3 | 2020 | 940 | 0.240 |
Why?
| Citric Acid Cycle | 2 | 2021 | 45 | 0.240 |
Why?
| Catecholamines | 1 | 2023 | 100 | 0.230 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 574 | 0.230 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 404 | 0.230 |
Why?
| Circadian Clocks | 1 | 2023 | 48 | 0.230 |
Why?
| Adiponectin | 3 | 2015 | 226 | 0.230 |
Why?
| Mitochondrial Diseases | 1 | 2023 | 79 | 0.230 |
Why?
| Isophane Insulin, Human | 1 | 2022 | 5 | 0.220 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2022 | 23 | 0.220 |
Why?
| Oxygen Consumption | 4 | 2016 | 586 | 0.220 |
Why?
| Fatty Liver | 2 | 2016 | 253 | 0.220 |
Why?
| Gluconeogenesis | 2 | 2018 | 66 | 0.220 |
Why?
| Sex Characteristics | 4 | 2021 | 671 | 0.220 |
Why?
| Adipokines | 1 | 2022 | 46 | 0.220 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 82 | 0.210 |
Why?
| Case-Control Studies | 5 | 2019 | 3171 | 0.210 |
Why?
| Blotting, Western | 3 | 2016 | 1194 | 0.210 |
Why?
| Interleukin-13 | 1 | 2022 | 135 | 0.210 |
Why?
| Dinoprostone | 1 | 2022 | 193 | 0.210 |
Why?
| Subcellular Fractions | 2 | 2021 | 84 | 0.210 |
Why?
| Biopsy | 3 | 2018 | 1079 | 0.210 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2023 | 200 | 0.210 |
Why?
| Histone Deacetylases | 1 | 2023 | 198 | 0.210 |
Why?
| Paracrine Communication | 1 | 2022 | 57 | 0.210 |
Why?
| Exercise Test | 5 | 2015 | 551 | 0.200 |
Why?
| Stearoyl-CoA Desaturase | 3 | 2012 | 57 | 0.200 |
Why?
| Interleukin-8 | 1 | 2022 | 249 | 0.200 |
Why?
| Bone Marrow | 1 | 2023 | 255 | 0.200 |
Why?
| Lipolysis | 2 | 2018 | 42 | 0.200 |
Why?
| Bone Remodeling | 1 | 2021 | 64 | 0.190 |
Why?
| Knee | 1 | 2001 | 52 | 0.190 |
Why?
| Diabetic Angiopathies | 3 | 2011 | 260 | 0.190 |
Why?
| Electric Stimulation | 1 | 2001 | 268 | 0.180 |
Why?
| Diabetic Neuropathies | 1 | 2021 | 78 | 0.180 |
Why?
| Immunity | 1 | 2020 | 129 | 0.180 |
Why?
| Antigens, Surface | 1 | 2000 | 156 | 0.180 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 359 | 0.180 |
Why?
| Hyperinsulinism | 2 | 2019 | 107 | 0.180 |
Why?
| Autophagy-Related Proteins | 2 | 2017 | 46 | 0.180 |
Why?
| Palmitic Acid | 2 | 2010 | 38 | 0.180 |
Why?
| Autoantigens | 2 | 2000 | 397 | 0.170 |
Why?
| Calorimetry, Indirect | 3 | 2019 | 72 | 0.170 |
Why?
| Guanosine Triphosphate | 1 | 2018 | 87 | 0.170 |
Why?
| Obesity, Abdominal | 1 | 2018 | 39 | 0.170 |
Why?
| Interleukin-6 | 1 | 2022 | 688 | 0.170 |
Why?
| rac1 GTP-Binding Protein | 1 | 2018 | 58 | 0.160 |
Why?
| Kinetics | 6 | 2006 | 1624 | 0.160 |
Why?
| Primary Cell Culture | 1 | 2019 | 155 | 0.160 |
Why?
| Basal Metabolism | 2 | 2008 | 50 | 0.160 |
Why?
| Rats | 3 | 2022 | 5392 | 0.160 |
Why?
| Muscle Contraction | 1 | 2001 | 413 | 0.160 |
Why?
| Cohort Studies | 5 | 2021 | 5116 | 0.160 |
Why?
| Diet | 4 | 2013 | 1153 | 0.150 |
Why?
| Diet, Western | 3 | 2023 | 69 | 0.150 |
Why?
| Cell Nucleus | 1 | 2020 | 580 | 0.150 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1171 | 0.150 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 280 | 0.150 |
Why?
| Autophagy-Related Protein-1 Homolog | 1 | 2017 | 7 | 0.150 |
Why?
| Metabolomics | 3 | 2019 | 550 | 0.150 |
Why?
| Metabolic Syndrome | 2 | 2013 | 394 | 0.150 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2017 | 48 | 0.150 |
Why?
| Biological Transport | 1 | 2017 | 382 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 409 | 0.140 |
Why?
| Phosphorylation | 4 | 2015 | 1633 | 0.140 |
Why?
| Mice | 12 | 2023 | 15520 | 0.140 |
Why?
| Gene Expression Profiling | 2 | 2023 | 1597 | 0.140 |
Why?
| Biomarkers | 4 | 2023 | 3588 | 0.140 |
Why?
| Metformin | 1 | 2019 | 295 | 0.130 |
Why?
| Fatty Acids, Unsaturated | 1 | 2016 | 86 | 0.130 |
Why?
| Weight Gain | 1 | 2019 | 493 | 0.130 |
Why?
| Microtubule-Associated Proteins | 1 | 2017 | 188 | 0.130 |
Why?
| Circadian Rhythm | 1 | 2019 | 401 | 0.130 |
Why?
| Insulin Receptor Substrate Proteins | 2 | 2012 | 58 | 0.130 |
Why?
| Insulinoma | 2 | 1999 | 29 | 0.130 |
Why?
| Amino Acids | 1 | 2019 | 465 | 0.130 |
Why?
| Mitochondria | 2 | 2018 | 786 | 0.130 |
Why?
| Pain | 1 | 2001 | 735 | 0.130 |
Why?
| Oxygen | 2 | 2015 | 854 | 0.130 |
Why?
| Algorithms | 3 | 2015 | 1541 | 0.130 |
Why?
| Cell Hypoxia | 1 | 2015 | 220 | 0.120 |
Why?
| Coronary Artery Disease | 2 | 2011 | 647 | 0.120 |
Why?
| Extracellular Vesicles | 1 | 2015 | 76 | 0.120 |
Why?
| Receptors, AMPA | 1 | 2015 | 125 | 0.120 |
Why?
| RNA, Messenger | 3 | 2014 | 2657 | 0.120 |
Why?
| Somatostatin | 1 | 2014 | 53 | 0.120 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 576 | 0.120 |
Why?
| Pregnancy | 6 | 2023 | 5691 | 0.120 |
Why?
| Adolescent | 11 | 2023 | 18480 | 0.120 |
Why?
| Neurodegenerative Diseases | 1 | 2015 | 99 | 0.120 |
Why?
| Fetal Development | 1 | 2016 | 250 | 0.120 |
Why?
| Cytoplasmic Granules | 1 | 1994 | 84 | 0.120 |
Why?
| Clone Cells | 4 | 2000 | 248 | 0.120 |
Why?
| Regression Analysis | 1 | 2016 | 983 | 0.110 |
Why?
| Leg | 3 | 1999 | 234 | 0.110 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 228 | 0.110 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 468 | 0.110 |
Why?
| Medroxyprogesterone Acetate | 1 | 2012 | 30 | 0.110 |
Why?
| Macaca | 3 | 2018 | 54 | 0.110 |
Why?
| Fructose | 1 | 2014 | 204 | 0.110 |
Why?
| Myocardial Reperfusion Injury | 1 | 2013 | 105 | 0.110 |
Why?
| Taxoids | 1 | 2012 | 98 | 0.110 |
Why?
| Phospholipids | 2 | 2012 | 208 | 0.110 |
Why?
| Hypoxia | 1 | 2018 | 963 | 0.110 |
Why?
| Cholesterol | 2 | 2013 | 373 | 0.110 |
Why?
| Coronary Vessels | 2 | 2010 | 233 | 0.100 |
Why?
| Progestins | 1 | 2012 | 77 | 0.100 |
Why?
| Hemodynamics | 3 | 2008 | 1004 | 0.100 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 1032 | 0.100 |
Why?
| Absorptiometry, Photon | 3 | 2019 | 229 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2019 | 2445 | 0.100 |
Why?
| Recovery of Function | 1 | 2015 | 604 | 0.100 |
Why?
| Reference Values | 2 | 2010 | 774 | 0.100 |
Why?
| Myocardial Contraction | 1 | 2013 | 339 | 0.100 |
Why?
| Fenofibrate | 1 | 2011 | 24 | 0.100 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1868 | 0.100 |
Why?
| Estradiol | 2 | 2019 | 476 | 0.100 |
Why?
| Sitagliptin Phosphate | 1 | 2010 | 30 | 0.090 |
Why?
| Hypolipidemic Agents | 1 | 2011 | 86 | 0.090 |
Why?
| Nicotine | 1 | 2012 | 276 | 0.090 |
Why?
| C-Peptide | 1 | 2010 | 137 | 0.090 |
Why?
| Retinoid X Receptor gamma | 1 | 2009 | 4 | 0.090 |
Why?
| Mice, Inbred C57BL | 2 | 2023 | 4908 | 0.090 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2012 | 369 | 0.090 |
Why?
| PPAR alpha | 1 | 2009 | 56 | 0.090 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2010 | 103 | 0.090 |
Why?
| Metabolic Clearance Rate | 2 | 2006 | 113 | 0.090 |
Why?
| Bicycling | 1 | 2010 | 77 | 0.090 |
Why?
| Lipoproteins | 1 | 2010 | 162 | 0.090 |
Why?
| Expiratory Reserve Volume | 1 | 2008 | 1 | 0.090 |
Why?
| Coronary Circulation | 1 | 2008 | 121 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 982 | 0.080 |
Why?
| Gene Expression | 3 | 2023 | 1489 | 0.080 |
Why?
| Ethinyl Estradiol | 1 | 1988 | 17 | 0.080 |
Why?
| Calcinosis | 1 | 2011 | 282 | 0.080 |
Why?
| Signal Transduction | 4 | 2018 | 4709 | 0.080 |
Why?
| Pancreatic Neoplasms | 2 | 1999 | 734 | 0.080 |
Why?
| Drug Resistance, Neoplasm | 1 | 2012 | 671 | 0.080 |
Why?
| Calcium | 2 | 2010 | 1169 | 0.080 |
Why?
| Arteries | 2 | 2000 | 250 | 0.080 |
Why?
| Regional Blood Flow | 2 | 1999 | 418 | 0.080 |
Why?
| Receptor, Insulin | 1 | 2007 | 100 | 0.080 |
Why?
| Cardiovascular Diseases | 3 | 2018 | 1798 | 0.070 |
Why?
| Overweight | 1 | 2011 | 502 | 0.070 |
Why?
| Hyperphagia | 1 | 2006 | 32 | 0.070 |
Why?
| Adaptation, Physiological | 1 | 2010 | 502 | 0.070 |
Why?
| Sex Factors | 4 | 2018 | 1781 | 0.070 |
Why?
| Child | 7 | 2019 | 19129 | 0.070 |
Why?
| Heart | 1 | 2009 | 631 | 0.070 |
Why?
| Substance Withdrawal Syndrome | 1 | 1988 | 157 | 0.070 |
Why?
| Sex Hormone-Binding Globulin | 2 | 2019 | 49 | 0.060 |
Why?
| Metabolome | 2 | 2019 | 296 | 0.060 |
Why?
| Ubiquinone | 1 | 2023 | 25 | 0.060 |
Why?
| Uncoupling Protein 1 | 1 | 2023 | 16 | 0.060 |
Why?
| ARNTL Transcription Factors | 1 | 2023 | 16 | 0.060 |
Why?
| Electron Transport | 1 | 2023 | 101 | 0.060 |
Why?
| Pyruvic Acid | 1 | 2004 | 48 | 0.060 |
Why?
| Thermogenesis | 1 | 2023 | 43 | 0.060 |
Why?
| Carbohydrate Metabolism | 2 | 2004 | 50 | 0.060 |
Why?
| Adipose Tissue, Brown | 1 | 2023 | 71 | 0.060 |
Why?
| Cell Line | 4 | 2018 | 2707 | 0.060 |
Why?
| Physical Exertion | 1 | 2004 | 222 | 0.060 |
Why?
| Prognosis | 2 | 2023 | 3443 | 0.060 |
Why?
| Neoplasms | 1 | 2017 | 2179 | 0.050 |
Why?
| Insulin, Regular, Human | 1 | 2022 | 32 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2010 | 2674 | 0.050 |
Why?
| Primates | 1 | 2023 | 114 | 0.050 |
Why?
| Diet, High-Fat | 1 | 2023 | 247 | 0.050 |
Why?
| Protein Binding | 2 | 2018 | 1975 | 0.050 |
Why?
| Time Factors | 2 | 2010 | 6412 | 0.050 |
Why?
| Body Weight | 1 | 2006 | 934 | 0.050 |
Why?
| Osteocalcin | 1 | 2021 | 35 | 0.050 |
Why?
| Swine, Miniature | 2 | 2013 | 71 | 0.050 |
Why?
| Aged | 5 | 2011 | 19657 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 2025 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 2012 | 1974 | 0.050 |
Why?
| Adenocarcinoma | 1 | 1988 | 812 | 0.050 |
Why?
| Ranolazine | 1 | 2020 | 21 | 0.050 |
Why?
| Proteins | 2 | 2015 | 938 | 0.050 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2015 | 211 | 0.050 |
Why?
| Oxidative Stress | 2 | 2018 | 1178 | 0.050 |
Why?
| Torque | 1 | 2001 | 67 | 0.050 |
Why?
| Testosterone | 2 | 2019 | 351 | 0.050 |
Why?
| Collagen Type I | 1 | 2021 | 114 | 0.050 |
Why?
| Electrodes | 1 | 2001 | 89 | 0.050 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 51 | 0.050 |
Why?
| Detergents | 1 | 2000 | 44 | 0.050 |
Why?
| Cytotoxicity, Immunologic | 1 | 2020 | 204 | 0.050 |
Why?
| Chromatography, Gel | 1 | 2000 | 133 | 0.050 |
Why?
| Serine | 1 | 2021 | 138 | 0.050 |
Why?
| L-Lactate Dehydrogenase | 1 | 2000 | 112 | 0.050 |
Why?
| Tumor Burden | 1 | 2020 | 274 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 332 | 0.040 |
Why?
| Solubility | 1 | 2000 | 235 | 0.040 |
Why?
| Infant | 2 | 2023 | 8293 | 0.040 |
Why?
| Isometric Contraction | 1 | 2001 | 155 | 0.040 |
Why?
| Mice, SCID | 1 | 2000 | 333 | 0.040 |
Why?
| Glycogen | 1 | 1999 | 59 | 0.040 |
Why?
| Cell Membrane | 2 | 2000 | 710 | 0.040 |
Why?
| Glucagon | 1 | 1999 | 97 | 0.040 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2000 | 170 | 0.040 |
Why?
| Eating | 1 | 2021 | 369 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 420 | 0.040 |
Why?
| Pilot Projects | 1 | 2023 | 1419 | 0.040 |
Why?
| Disease Models, Animal | 3 | 2015 | 3730 | 0.040 |
Why?
| Glucose Transporter Type 4 | 1 | 2018 | 38 | 0.040 |
Why?
| Swine | 2 | 2013 | 730 | 0.040 |
Why?
| Osmolar Concentration | 1 | 1999 | 185 | 0.040 |
Why?
| Postprandial Period | 1 | 1999 | 96 | 0.040 |
Why?
| Perception | 1 | 2001 | 314 | 0.040 |
Why?
| Muscle Proteins | 1 | 2000 | 219 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2020 | 356 | 0.040 |
Why?
| Dendritic Cells | 1 | 2020 | 442 | 0.040 |
Why?
| Immunity, Innate | 1 | 2023 | 745 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| Carbon Dioxide | 1 | 1999 | 230 | 0.040 |
Why?
| Cell Line, Tumor | 2 | 2015 | 2851 | 0.040 |
Why?
| Cell Proliferation | 2 | 2015 | 2275 | 0.040 |
Why?
| Nutritional Status | 1 | 1999 | 300 | 0.040 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2017 | 97 | 0.040 |
Why?
| Carrier Proteins | 1 | 2000 | 726 | 0.030 |
Why?
| Deuterium | 1 | 2015 | 78 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2020 | 702 | 0.030 |
Why?
| Prospective Studies | 2 | 2018 | 6471 | 0.030 |
Why?
| Waist Circumference | 1 | 2015 | 130 | 0.030 |
Why?
| Androgens | 1 | 2016 | 167 | 0.030 |
Why?
| HeLa Cells | 1 | 2017 | 583 | 0.030 |
Why?
| Double-Blind Method | 1 | 2019 | 1687 | 0.030 |
Why?
| Lymphocyte Activation | 3 | 1994 | 1067 | 0.030 |
Why?
| Epitopes | 1 | 1997 | 443 | 0.030 |
Why?
| Protein Subunits | 1 | 2015 | 211 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2020 | 1059 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 41 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 80 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 53 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 462 | 0.030 |
Why?
| Animal Feed | 1 | 2014 | 55 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1055 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1997 | 359 | 0.030 |
Why?
| Memory | 1 | 2015 | 230 | 0.030 |
Why?
| Risk Factors | 3 | 2012 | 9000 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 1994 | 405 | 0.030 |
Why?
| Prevalence | 1 | 2019 | 2326 | 0.030 |
Why?
| Acyl Coenzyme A | 1 | 2013 | 30 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 315 | 0.030 |
Why?
| Macrophage Activation | 1 | 2014 | 168 | 0.030 |
Why?
| Amyloid beta-Peptides | 1 | 2015 | 200 | 0.030 |
Why?
| Heart Function Tests | 1 | 2013 | 61 | 0.030 |
Why?
| Gonanes | 1 | 2012 | 28 | 0.030 |
Why?
| Cardiolipins | 1 | 2013 | 73 | 0.030 |
Why?
| Anaerobic Threshold | 2 | 2004 | 21 | 0.030 |
Why?
| Fetus | 1 | 2016 | 690 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 1994 | 874 | 0.030 |
Why?
| Behavior, Animal | 1 | 2015 | 486 | 0.030 |
Why?
| Antigen-Presenting Cells | 1 | 1992 | 156 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2015 | 416 | 0.030 |
Why?
| Abdominal Fat | 1 | 2012 | 48 | 0.030 |
Why?
| Models, Statistical | 1 | 2015 | 636 | 0.030 |
Why?
| Models, Theoretical | 1 | 2015 | 556 | 0.030 |
Why?
| Molecular Weight | 1 | 2012 | 343 | 0.030 |
Why?
| Learning | 1 | 2015 | 374 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 292 | 0.020 |
Why?
| Tomography, X-Ray Computed | 2 | 2010 | 2436 | 0.020 |
Why?
| Cognition Disorders | 1 | 2015 | 529 | 0.020 |
Why?
| Hippocampus | 1 | 2015 | 735 | 0.020 |
Why?
| Receptors, Progesterone | 1 | 2012 | 325 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2011 | 198 | 0.020 |
Why?
| Abdomen | 1 | 2010 | 110 | 0.020 |
Why?
| Genotype | 1 | 2015 | 1882 | 0.020 |
Why?
| Sex Distribution | 1 | 2010 | 351 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2018 | 4596 | 0.020 |
Why?
| Mice, Knockout | 1 | 2015 | 2680 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 525 | 0.020 |
Why?
| Spleen | 1 | 2010 | 510 | 0.020 |
Why?
| Environmental Monitoring | 1 | 2010 | 296 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2010 | 355 | 0.020 |
Why?
| Leydig Cells | 1 | 1988 | 12 | 0.020 |
Why?
| Gonadotropins, Pituitary | 1 | 1988 | 22 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 341 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2018 | 3174 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2484 | 0.020 |
Why?
| B-Lymphocytes | 1 | 1992 | 770 | 0.020 |
Why?
| Macrophages | 1 | 2014 | 1324 | 0.020 |
Why?
| Patient Selection | 1 | 2010 | 676 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 1900 | 0.020 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 387 | 0.020 |
Why?
| Amino Acid Sequence | 2 | 2000 | 2071 | 0.020 |
Why?
| Molecular Sequence Data | 2 | 2000 | 2871 | 0.020 |
Why?
| Age Factors | 1 | 2012 | 2995 | 0.020 |
Why?
| Femoral Vein | 1 | 2004 | 29 | 0.020 |
Why?
| Alanine | 1 | 2004 | 102 | 0.010 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2004 | 135 | 0.010 |
Why?
| Hormones | 1 | 2004 | 135 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2566 | 0.010 |
Why?
| Glycolysis | 1 | 2004 | 224 | 0.010 |
Why?
| Blood Pressure | 1 | 2009 | 1664 | 0.010 |
Why?
| Femoral Artery | 1 | 2004 | 175 | 0.010 |
Why?
| Weight Loss | 1 | 2006 | 655 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 2010 | 942 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2012 | 1965 | 0.010 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2000 | 22 | 0.010 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 61 | 0.010 |
Why?
| Glucose-6-Phosphatase | 1 | 1999 | 32 | 0.010 |
Why?
| Mice, Obese | 1 | 1999 | 58 | 0.010 |
Why?
| Isoenzymes | 1 | 2000 | 297 | 0.010 |
Why?
| Fishes | 1 | 1999 | 85 | 0.010 |
Why?
| Open Reading Frames | 1 | 1999 | 121 | 0.010 |
Why?
| Myosin Heavy Chains | 1 | 2000 | 192 | 0.010 |
Why?
| Conserved Sequence | 1 | 1999 | 219 | 0.010 |
Why?
| Sequence Alignment | 1 | 1999 | 336 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 372 | 0.010 |
Why?
| Exons | 1 | 1999 | 307 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 1999 | 338 | 0.010 |
Why?
| Dogs | 1 | 1999 | 371 | 0.010 |
Why?
| Cloning, Molecular | 1 | 1999 | 546 | 0.010 |
Why?
| Alternative Splicing | 1 | 1999 | 193 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1999 | 1206 | 0.010 |
Why?
| Base Sequence | 1 | 1999 | 2159 | 0.010 |
Why?
| Models, Molecular | 1 | 1999 | 1435 | 0.010 |
Why?
| Genetic Variation | 1 | 1999 | 926 | 0.010 |
Why?
| Trinitrobenzenes | 1 | 1992 | 13 | 0.010 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.010 |
Why?
| Haptens | 1 | 1992 | 22 | 0.010 |
Why?
| Hybrid Cells | 1 | 1992 | 46 | 0.010 |
Why?
| Ovalbumin | 1 | 1992 | 165 | 0.010 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 101 | 0.010 |
Why?
| Interleukin-2 | 1 | 1992 | 416 | 0.010 |
Why?
| Islets of Langerhans Transplantation | 1 | 1989 | 68 | 0.010 |
Why?
| Mice, Mutant Strains | 1 | 1989 | 280 | 0.010 |
Why?
| Pituitary Gland | 1 | 1989 | 163 | 0.010 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|